Journal reputation -neurology

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

newaccount4decisionss

Full Member
Joined
Apr 23, 2020
Messages
15
Reaction score
25
Can a neurologist elaborate on the reputation of each of the following journals (for publications for residency application)? Posting for an MS2 friend who is submitting a 1st co-author manuscript.

Brain: A Journal of Neurology
Alzheimer's and Dementia: the Journal of Alzheimer's Association
Acta Neuropathologica
Neurology- AAN
JAMA Neurology

Members don't see this ad.
 
Members don't see this ad :)
Search impact factor.

Generally speaking (IMO):

Tier 1: Annals, JAMA Neurology, Brain, Lancet neuro
Tier 1a: Green journal (Neurology)

Tier 2: Top subspecialty journals (e.g. Stroke, Alz and Dementia, Movement Disorders)

Tier 3: Other less-known legitimate traditional journals, subspecialty and otherwise (e.g. Parkinsonism related disorders), "clinical practice" journals, high quality open access journals (e.g. Frontiers)

Tier 4 (be careful): Smaller open access journals

Avoid: pop-up and predatory open access journals, any journal that emails you asking for submissions (unless you're a highly established name in your field with many dozens of publications)
 
Does having a first author pub in tier 1-2 journals open doors for top residency like MGH? (Does it stand out?)
How common is it among applicants?
thankyou
 
You aren't getting a first author pub in a high impact factor journal as a med student unless you do a PhD, and probably not even then.
 
You aren't getting a first author pub in a high impact factor journal as a med student unless you do a PhD, and probably not even then.

Why not? I think translational/clinical research is very do-able (as compared to basic science).
I am pretty sure plenty of med students have published first-author papers at high impact (>IF 10) before. I don't think it's rare?
 
Why not? I think translational/clinical research is very do-able (as compared to basic science).
I am pretty sure plenty of med students have published first-author papers at high impact (>IF 10) before. I don't think it's rare?


high IF journals want credibility in the names they publish. That's why you need some big shot as PI to accompany your article. JAMA did that to me, was quite ironic when they denied my paper but when another "big shot" published very similar data with lots of mistakes they accepted it... I got into JAMA by correcting their mistakes in a letter to the editor.
 
Why not? I think translational/clinical research is very do-able (as compared to basic science).
I am pretty sure plenty of med students have published first-author papers at high impact (>IF 10) before. I don't think it's rare?
The kind of clinical studies that get into high IF journals represent years of work for the lead authors who are generally themselves experienced investigators. These aren't your summer research project. Please tell me when in your med school curriculum you have that kind of time to dedicate to a project of that magnitude without taking a PhD or similar time off.

Honestly the perspective on publishing exhibited in this thread is exactly what I would be looking to weed out if I were a program director. Publishing for publishing's sake should not be a goal and it's fairly easy to tell when someone has been resume-padding with publications. Developing a research project you want to work on long term is far more valuable but takes real time.
 
I agree with most everything Thama said here. Some of the subspecialty journals like Stroke are more on par with Neurology with regard to reputation/impact. I can't remember the last time I interviewed a medical student with a high impact publication unless they were 5th author or took significant time off to do research such as an MD/PhD student.
 
Top